SAN FRANCISCO, CA--(Marketwire - September 04, 2008) - As part of its commitment to providing its customers with comprehensive services that span the entire clinical supply chain, Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial supplies and services, has enhanced its global Phase III capabilities. Its latest Phase III investments include the upgrade of its Kalish large-scale bottling line at its U.S. facility and an investment in new Pentapack blistering technology for expanded packaging capabilities in America and Europe.
